hotspot -WSS

hotspot

author：knowledge 2025-10-01 18:03:30 - browse：2396

Are biotech’s dog days over? What’s a PIPE? And what can unseat Wegovy?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We dive into the the latest craze in the world of biotech finance, involving hedge funds and some insider information, and explain why not everyone thinks it’s such a good idea. We also discuss a banner month for biotech stocks and the latest twist in obesity research.

For more on what we cover, here’s more on PIPEs; here’s the news from Viking Therapeutics; here’s the latest in MASH; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Generate Biomedicines machine learning biotech raises $273M

leisure time

WSS

Long Covid needs a new name — and a new frame

WATCH: Why do bright lights make us see spots?

Diverse clinical trials: Why aren’t we there yet?

Food makers tried to stack nutrition panel with preferred experts

Walmart eyes Medicare Advantage provider ChenMed

FDA approves updated Covid vaccines

knowledge

hotspot

explore

In Memoriam: Notable people who died in 2023

Patients, doctors press FTC to beef up hospital merger scrutiny

Novavax promises a turnaround & Lilly roils the obesity market

The unintended consequences of overturning Roe v. Wade

Medicare details structure of new drug price negotiation program

Senate bill would ban some hospital facility fees

Jerome Adams on the need for new antivirals for Covid

Food makers to regulators: Ultra

Peter Hotez and the public health issue of online harassment

How to make the FDA’s new prescription one

knowledge

Neurocrine congenital adrenal hyperplasia trial succeeds

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Private equity could exacerbate cardiology's overuse problem, experts fear

Food makers tried to stack nutrition panel with preferred experts

'A game

Information blocking fines are now fair game in health care

hotspot

leisure time

entertainment

focus